Treace Medical Concepts (TMCI) Non-Current Debt (2020 - 2026)

Treace Medical Concepts' Non-Current Debt history runs 7 years deep, the most recent figure standing at $55.8 million for Q1 2026.

• Quarterly Non-Current Debt rose 4.57% year-over-year to $55.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55.8 million (up 4.57% YoY) and the FY2025 annual result came in at $55.6 million, up 4.27% from the prior year.
• Non-Current Debt was $55.8 million for Q1 2026 at Treace Medical Concepts, roughly flat from $55.6 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $55.8 million in Q1 2026 and bottomed at $29.4 million in Q1 2022.
• A 5-year average of $52.0 million and a median of $53.1 million in 2024 frame the typical range for Non-Current Debt.
• Annual changes were most pronounced in 2022 — Non-Current Debt surged 79.53% — and 2025, when it gained 0.56%.
• Treace Medical Concepts' Non-Current Debt stood at $52.7 million in 2022, then advanced by 0.56% to $53.0 million in 2023, then advanced by 0.56% to $53.3 million in 2024, then grew by 4.27% to $55.6 million in 2025, then advanced by 0.43% to $55.8 million in 2026.
• Business Quant data shows TMCI's Non-Current Debt at $55.8 million in Q1 2026, $55.6 million in Q4 2025, and $53.5 million in Q3 2025.